Table 3 SMD before and after PSM analysis.

From: Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B

Variable

Before PSM

After PSM

VR (n = 188)

No VR (n = 64)

P

SMD

VR (n = 124)

No VR (n = 39)

P

SMD

Age

52.00 (44.00, 58.00)

58.00 (52.00, 65.25)

 < 0.001

0.510

52.00 (44.75, 59.00)

55.00 (47.00, 58.50)

0.661

0.068

Portal vein diameter

1.00 (1.00, 1.20)

1.20 (1.00, 1.52)

0.008

0.443

1.10 (1.00, 1.30)

1.00 (1.00, 1.20)

0.352

0.030

Spleen major axis

11.15 (9.60, 12.30)

13.45 (10.83, 17.45)

 < 0.001

0.687

12.00 (9.70, 13.03)

11.90 (9.90, 14.10)

0.784

0.160

AFP

2.30 (1.72, 3.53)

5.84 (2.15, 108.03)

 < 0.001

0.196

2.30 (1.72, 3.59)

2.85 (1.63, 11.10)

0.174

0.123

D-dimer

360.00 (167.50, 565.43)

520.74 (267.50, 1542.50)

 < 0.001

0.475

360.00 (167.50, 583.26)

387.00 (195.00, 691.09)

0.377

0.119

INR

1.12 (1.02, 1.15)

1.15 (1.07, 1.28)

0.001

0.402

1.12 (1.03, 1.16)

1.14 (1.06, 1.16)

0.597

0.101

APTT

34.29 (31.50, 37.15)

35.50 (32.30, 38.85)

0.057

0.257

34.57 (31.60, 37.15)

34.20 (31.35, 37.60)

0.952

0.063

Fib

2.10 (1.96, 2.31)

2.10 (1.73, 2.34)

0.572

 − 0.018

2.08 (1.88, 2.31)

2.12 (1.92, 2.31)

0.765

0.085

PT

12.90 (11.80, 13.31)

13.26 (12.47, 14.88)

 < 0.001

0.427

12.96 (11.90, 13.43)

13.12 (12.15, 13.36)

0.550

0.148

Platelet count

133.91 (91.75, 167.50)

89.50 (61.00, 145.50)

 < 0.001

 − 0.517

125.50 (86.00, 165.00)

112.00 (85.00, 172.00)

0.800

 − 0.058

MPV

10.50 (9.80, 11.20)

10.55 (9.97, 11.30)

0.435

0.161

10.45 (9.78, 11.30)

10.50 (10.00, 11.15)

0.835

 − 0.009

ALT

41.00 (27.00, 80.25)

45.10 (29.00, 77.68)

0.623

0.006

42.15 (27.00, 81.12)

40.00 (28.75, 74.40)

0.737

0.023

AST

32.90 (25.00, 58.75)

42.88 (25.93, 83.11)

0.073

0.154

34.15 (26.00, 63.20)

34.00 (24.80, 58.60)

0.692

0.089

GGT

28.00 (19.00, 63.00)

42.65 (29.95, 84.17)

0.002

0.241

27.75 (19.88, 63.00)

38.70 (20.90, 61.70)

0.230

0.141

ALP

71.80 (56.48, 92.00)

87.10 (63.98, 111.30)

0.010

0.355

73.80 (59.00, 91.22)

80.40 (61.50, 102.50)

0.364

0.118

Total bilirubin

19.18 (14.33, 25.86)

24.88 (19.05, 36.17)

 < 0.001

0.258

19.18 (14.39, 25.06)

23.70 (17.00, 29.69)

0.064

0.172

LDL

2.48 (2.08, 2.74)

2.37 (1.92, 2.60)

0.059

 − 0.404

2.42 (1.96, 2.63)

2.44 (1.97, 2.62)

0.772

 − 0.030

HDL

1.39 (1.13, 1.46)

1.25 (0.96, 1.42)

0.006

0.058

1.38 (1.13, 1.46)

1.39 (0.98, 1.43)

0.610

 − 0.188

TG

1.00 (0.77, 1.13)

1.00 (0.77, 1.17)

0.715

0.124

0.99 (0.78, 1.11)

1.06 (0.93, 1.19)

0.053

0.255

TC

4.27 (3.67, 4.84)

4.04 (3.34, 4.48)

0.027

 − 0.387

4.19 (3.50, 4.61)

4.20 (3.65, 4.57)

0.785

0.102

HBsAg

250.00 (230.31, 250.00)

239.17 (231.92, 250.00)

0.577

0.056

250.00 (230.45, 250.00)

232.50 (231.34, 250.00)

0.487

0.151

HBsAb

0.17 (0.00, 1.35)

0.06 (0.00, 0.74)

0.282

0.090

0.17 (0.00, 1.45)

0.00 (0.00, 0.68)

0.095

 − 1.766

Gender

  

0.072

   

0.413

 

 Male

121 (64.36)

49 (76.56)

 

0.288

87 (70.16)

30 (76.92)

 

0.160

 Female

67 (35.64)

15 (23.44)

 

 − 0.288

37 (29.84)

9 (23.08)

 

 − 0.160

Cirrhosis level

  

 < 0.001

   

0.263

 

 Compensatory

166 (88.30)

32 (50.00)

 

 − 0.766

105 (84.68)

30 (76.92)

 

 − 0.184

 Decompensatory

22 (11.70)

32 (50.00)

 

0.766

19 (15.32)

9 (23.08)

 

0.184

HCC

  

 < 0.001

   

0.390

 

 No

177 (94.15)

41 (64.06)

 

 − 0.627

113 (91.13)

33 (84.62)

 

 − 0.181

 Yes

11 (5.85)

23 (35.94)

 

0.627

11 (8.87)

6 (15.38)

 

0.181

Diabetes

  

1.000

   

0.781

 

 No

179 (95.21)

61 (95.31)

 

0.005

118 (95.16)

36 (92.31)

 

 − 0.107

 Yes

9 (4.79)

3 (4.69)

 

 − 0.005

6 (4.84)

3 (7.69)

 

0.107

Hypertension

  

0.738

   

0.335

 

 No

175 (93.09)

61 (95.31)

 

0.105

113 (91.13)

38 (97.44)

 

0.399

 Yes

13 (6.91)

3 (4.69)

 

 − 0.105

11 (8.87)

1 (2.56)

 

 − 0.399

HBeAg

  

0.842

   

0.571

 

 Negative

106 (56.38)

37 (57.81)

 

0.029

70 (56.45)

20 (51.28)

 

 − 0.103

 Positive

82 (43.62)

27 (42.19)

 

 − 0.029

54 (43.55)

19 (48.72)

 

0.103

HBeAb

  

0.613

   

0.184

 

 Negative

93 (49.47)

34 (53.12)

 

0.073

58 (46.77)

23 (58.97)

 

0.248

 Positive

95 (50.53)

30 (46.88)

 

 − 0.073

66 (53.23)

16 (41.03)

 

 − 0.248

  1. VR means patients achieved virological response, No VR means patients achieved a PVR, PNR, or VBT response. When P > 0.05 and SMD < 0.5, confounding factors were considered to be controlled.